当前蛋白身份:Q86U86 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2KTB Solution Structure of the Second Bromodomain of Human Polybromo in complex with an acetylated peptide from Histone 3 提交 2010-01-26 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 174–293(120 aa) 片段:Polybromo Bromdomain 2
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6.5;298 K;离子强度(mmCIF原始值)0.1;压力 ambient
NMR样品组成 0.5 mM [U-100% 15N] Polybromo Bromdomain2, 2.5 mM H3 Peptide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 0.5 mM [U-100% 13C; U-100% 15N] Polybromo Bromdomain2, 2.5 mM H3 Peptide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 0.8 mM [U-100% 13C; U-100% 15N] Polybromo Bromdomain2, 8 mM H3 Peptide, 100% D2O | 100% D2O
分辨率未提供
3G0J Crystal Structure of the fifth Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-01-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2M Na_nitrate, 25% w/v PEG 3350, 5% v/v ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.237
3G0J Crystal Structure of the fifth Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-01-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 3 NO3 NITRATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2M Na_nitrate, 25% w/v PEG 3350, 5% v/v ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.237
3HMF Crystal Structure of the second Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-05-29 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 178–291(114 aa) 片段:bromodomain, UNP residues 178-291
未记录 ZN ZINC ION × 2 EDO 1,2-ETHANEDIOL × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.01M Zn_Cl, 15w/v PEG_6000, 10v/v ethylene_glycol, 5.5pH MES, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.63 Å R-free 0.199
3HMF Crystal Structure of the second Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-05-29 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 178–291(114 aa) 片段:bromodomain, UNP residues 178-291
未记录 ZN ZINC ION × 4 EDO 1,2-ETHANEDIOL × 2 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.01M Zn_Cl, 15w/v PEG_6000, 10v/v ethylene_glycol, 5.5pH MES, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.63 Å R-free 0.199
3IU5 Crystal structure of the first bromodomain of human poly-bromodomain containing protein 1 (PB1) 提交 2009-08-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 43–154(112 aa) 片段:Bromo 1 domain: UNP residues 43-154
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;2.1M Na malate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.63 Å R-free 0.204
3IU6 Crystal structure of the sixth bromodomain of human poly-bromodomain containing protein 1 (PB1) 提交 2009-08-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 773–914(142 aa) 片段:Bromo 6 domain: UNP residues 773-914
非标准单体:是(mmCIF未提供具体位点) EDO 1,2-ETHANEDIOL × 3 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;0.01M ZnCl2, 0.1M Tris-HCl pH 8.0, 20% PEG 6000, 10% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.79 Å R-free 0.202
3K2J Crystal Structure of the 3rd Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-09-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 388–494(107 aa) 片段:Bromo 3 domain, UNP residues 388-494
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.1M NaOAc.3H20 pH 5.5, 1.1M (NH4)2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.20 Å R-free 0.270
3K2J Crystal Structure of the 3rd Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-09-30 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 388–494(107 aa) 片段:Bromo 3 domain, UNP residues 388-494
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.1M NaOAc.3H20 pH 5.5, 1.1M (NH4)2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.20 Å R-free 0.270
3K2J Crystal Structure of the 3rd Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) 提交 2009-09-30 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 388–494(107 aa) 片段:Bromo 3 domain, UNP residues 388-494
链 B 388–494(107 aa) 片段:Bromo 3 domain, UNP residues 388-494
未记录 CL CHLORIDE ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.1M NaOAc.3H20 pH 5.5, 1.1M (NH4)2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.20 Å R-free 0.270
3LJW Crystal Structure of the Second Bromodomain of Human Polybromo 提交 2010-01-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 174–293(120 aa) 片段:Bromodomain 2 (UNP residues 174-293)
未记录 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;35% PEG 4000, 10 mM Sodium Acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
分辨率 1.50 Å R-free 0.197
3LJW Crystal Structure of the Second Bromodomain of Human Polybromo 提交 2010-01-26 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 174–293(120 aa) 片段:Bromodomain 2 (UNP residues 174-293)
未记录 ACT ACETATE ION × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;35% PEG 4000, 10 mM Sodium Acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
分辨率 1.50 Å R-free 0.197
3MB4 Crystal Structure of the fifth Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) with NMP 提交 2010-03-25 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 2 MB3 1-methylpyrrolidin-2-one × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.15M NaNO3 25% PEG 3350 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.66 Å R-free 0.219
3MB4 Crystal Structure of the fifth Bromodomain of Human Poly-bromodomain containing protein 1 (PB1) with NMP 提交 2010-03-25 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 3 MB3 1-methylpyrrolidin-2-one × 1 CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.15M NaNO3 25% PEG 3350 10% Ethylene Glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.66 Å R-free 0.219
3TLP Crystal structure of the fourth bromodomain of human poly-bromodomain containing protein 1 (PB1) 提交 2011-08-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 496–637(142 aa) 片段:UNP residues 496-637
未记录 NI NICKEL (II) ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;25% PEG_MME_2000, 0.015M NiCl, 0.1M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.13 Å R-free 0.249
3TLP Crystal structure of the fourth bromodomain of human poly-bromodomain containing protein 1 (PB1) 提交 2011-08-30 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 496–637(142 aa) 片段:UNP residues 496-637
未记录 NI NICKEL (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;25% PEG_MME_2000, 0.015M NiCl, 0.1M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.13 Å R-free 0.249
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 1 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa) 片段:UNP residues 645-766
未记录 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 1 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 1 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 2 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 1 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 7 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 G 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 2 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0N Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 8 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 H 645–766(122 aa) 片段:UNP residues 645-766
未记录 EDO 1,2-ETHANEDIOL × 1 2XD (2E)-1-(2-hydroxyphenyl)-3-(2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M Na(malonate), 0.1M BTProp pH 6.5, 20.0% PEG 3350 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.78 Å R-free 0.214
4Q0O Crystal Structure of the fifth bromodomain of Human Poly-bromodomain containing protein 1 (PB1) in complex with a hydroxyphenyl-propenone ligand 提交 2014-04-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa) 片段:UNP residues 645-766
未记录 K POTASSIUM ION × 1 2XC (2E)-1-(2-hydroxyphenyl)-3-[(3R)-3-phenylpiperidin-1-yl]prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;0.20M K3(cit), 0.1M BTProp pH 6.5, 20.0% PEG 3350, 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 1.83 Å R-free 0.224
4Y03 Crystal Structure of the fifth bromodomain of human PB1 in complex with salicylic acid 提交 2015-02-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa) 片段:UNP residues 645-766
未记录 SAL 2-HYDROXYBENZOIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;K3(citrate), 20% PEG3350, 10% EtGly
分辨率 1.94 Å R-free 0.281
4Y03 Crystal Structure of the fifth bromodomain of human PB1 in complex with salicylic acid 提交 2015-02-05 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa) 片段:UNP residues 645-766
未记录 SAL 2-HYDROXYBENZOIC ACID × 1 CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;K3(citrate), 20% PEG3350, 10% EtGly
分辨率 1.94 Å R-free 0.281
5E7D Crystal Structure of the fifth bromodomain of human PB1 in complex with a hydroxyphenyl ligand 提交 2015-10-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa) 片段:UNP residues 645-766
未记录 5KL (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2M Na2SO4 20w/v PEG_3350 10v/v ethylene_glycol
分辨率 1.87 Å R-free 0.248
5E7D Crystal Structure of the fifth bromodomain of human PB1 in complex with a hydroxyphenyl ligand 提交 2015-10-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa) 片段:UNP residues 645-766
未记录 5KL (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2M Na2SO4 20w/v PEG_3350 10v/v ethylene_glycol
分辨率 1.87 Å R-free 0.248
5E7D Crystal Structure of the fifth bromodomain of human PB1 in complex with a hydroxyphenyl ligand 提交 2015-10-12 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 645–766(122 aa) 片段:UNP residues 645-766
未记录 5KL (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2M Na2SO4 20w/v PEG_3350 10v/v ethylene_glycol
分辨率 1.87 Å R-free 0.248
5E7D Crystal Structure of the fifth bromodomain of human PB1 in complex with a hydroxyphenyl ligand 提交 2015-10-12 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 645–766(122 aa) 片段:UNP residues 645-766
未记录 5KL (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2M Na2SO4 20w/v PEG_3350 10v/v ethylene_glycol
分辨率 1.87 Å R-free 0.248
5FH6 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 10 提交 2015-12-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 5XM (3~{R})-3-(piperidin-1-ylmethyl)-2,3-dihydro-1~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.2 M LiSO4, 0.1 M bis-tris pH 6.5, 25% PEG 3350
分辨率 2.30 Å R-free 0.310
5FH6 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 10 提交 2015-12-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 5XM (3~{R})-3-(piperidin-1-ylmethyl)-2,3-dihydro-1~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.2 M LiSO4, 0.1 M bis-tris pH 6.5, 25% PEG 3350
分辨率 2.30 Å R-free 0.310
5FH6 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 10 提交 2015-12-21 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 645–766(122 aa)
未记录 5XM (3~{R})-3-(piperidin-1-ylmethyl)-2,3-dihydro-1~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.2 M LiSO4, 0.1 M bis-tris pH 6.5, 25% PEG 3350
分辨率 2.30 Å R-free 0.310
5FH6 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 10 提交 2015-12-21 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 645–766(122 aa)
未记录 5XM (3~{R})-3-(piperidin-1-ylmethyl)-2,3-dihydro-1~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.2 M LiSO4, 0.1 M bis-tris pH 6.5, 25% PEG 3350
分辨率 2.30 Å R-free 0.310
5FH7 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 18 提交 2015-12-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 EDO 1,2-ETHANEDIOL × 2 5XL 6-chloranyl-3-[(dimethylamino)methyl]-4~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.1 M magnesium formate, 15% PEG 3350
分辨率 1.47 Å R-free 0.208
5FH7 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 18 提交 2015-12-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 5XL 6-chloranyl-3-[(dimethylamino)methyl]-4~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;0.1 M magnesium formate, 15% PEG 3350
分辨率 1.47 Å R-free 0.208
5FH8 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 28 提交 2015-12-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 5XK 6-chloranyl-3-(2-ethylbutyl)-4~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;10% MPD, 0.1 M bicine pH 9
分辨率 1.55 Å R-free 0.224
5FH8 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 28 提交 2015-12-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 5XK 6-chloranyl-3-(2-ethylbutyl)-4~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;10% MPD, 0.1 M bicine pH 9
分辨率 1.55 Å R-free 0.224
5FH8 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 28 提交 2015-12-21 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 645–766(122 aa)
未记录 5XK 6-chloranyl-3-(2-ethylbutyl)-4~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;10% MPD, 0.1 M bicine pH 9
分辨率 1.55 Å R-free 0.224
5FH8 Crystal structure of the fifth bromodomain of human PB1 in complex with compound 28 提交 2015-12-21 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 645–766(122 aa)
未记录 5XK 6-chloranyl-3-(2-ethylbutyl)-4~{H}-pyrrolo[1,2-a]quinazolin-5-one × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277.15 K;10% MPD, 0.1 M bicine pH 9
分辨率 1.55 Å R-free 0.224
5HRV Crystal structure of the fifth bromodomain of human PB1 in complex with 1-ethylisochromeno[3,4-c]pyrazol-5(2H)-one) compound 提交 2016-01-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 613–734(122 aa) 片段:UNP Residues 613-734
未记录 64C 1-ethylisochromeno[3,4-c]pyrazol-5(3H)-one × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1 M tris-sodium citrate dihydrate pH 5.6, 20% isopropanol, 20% PEG4K
分辨率 1.70 Å R-free 0.208
5HRW Crystal structure of the fifth bromodomain of human PB1 in complex with 1-propylisochromeno[3,4-c]pyrazol-5(2H)-one) compound 提交 2016-01-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 613–734(122 aa) 片段:UNP Residues 613-734
未记录 64E 1-propylisochromeno[3,4-c]pyrazol-5(3H)-one × 1 EDO 1,2-ETHANEDIOL × 4 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2 M ammonium sulfate, 0.1 M MES pH 6.5, 30% PEGMME5k
分辨率 1.80 Å R-free 0.236
5HRW Crystal structure of the fifth bromodomain of human PB1 in complex with 1-propylisochromeno[3,4-c]pyrazol-5(2H)-one) compound 提交 2016-01-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 613–734(122 aa) 片段:UNP Residues 613-734
未记录 64E 1-propylisochromeno[3,4-c]pyrazol-5(3H)-one × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.2 M ammonium sulfate, 0.1 M MES pH 6.5, 30% PEGMME5k
分辨率 1.80 Å R-free 0.236
5HRX Crystal structure of the fifth bromodomain of human PB1 in complex with 1-butylisochromeno[3,4-c]pyrazol-5(2H)-one) compound 提交 2016-01-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 613–734(122 aa) 片段:UNP Residues 613-734
未记录 EDO 1,2-ETHANEDIOL × 2 64F 1-butylisochromeno[3,4-c]pyrazol-5(3H)-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1M lithium sulfate monohydrate, 0.1 M Tris pH 8.5, 30% PEG4K
分辨率 1.73 Å R-free 0.254
5HRX Crystal structure of the fifth bromodomain of human PB1 in complex with 1-butylisochromeno[3,4-c]pyrazol-5(2H)-one) compound 提交 2016-01-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 613–734(122 aa) 片段:UNP Residues 613-734
未记录 64F 1-butylisochromeno[3,4-c]pyrazol-5(3H)-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.1M lithium sulfate monohydrate, 0.1 M Tris pH 8.5, 30% PEG4K
分辨率 1.73 Å R-free 0.254
5II1 Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 1-methylisochromeno[3,4-c]pyrazol-5(3H)-one 提交 2016-03-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 6BL 1-methyl[2]benzopyrano[3,4-c]pyrazol-5(3H)-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.1;277 K;18% PEG_3350 0.15M Na_malonate_pH7.0 10v/v ethylene_glycol 0.1M bis_tris_propane pH 8.1
分辨率 2.02 Å R-free 0.255
5II1 Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 1-methylisochromeno[3,4-c]pyrazol-5(3H)-one 提交 2016-03-01 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 6BL 1-methyl[2]benzopyrano[3,4-c]pyrazol-5(3H)-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.1;277 K;18% PEG_3350 0.15M Na_malonate_pH7.0 10v/v ethylene_glycol 0.1M bis_tris_propane pH 8.1
分辨率 2.02 Å R-free 0.255
5II2 Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one 提交 2016-03-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 K POTASSIUM ION × 1 CIT CITRIC ACID × 1 LU2 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.20M K3(cit) 0.1M BTProp pH 7.5 20.0% PEG 3350 10.0% EtGly
分辨率 2.10 Å R-free 0.227
5II2 Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one 提交 2016-03-01 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 K POTASSIUM ION × 1 LU2 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.20M K3(cit) 0.1M BTProp pH 7.5 20.0% PEG 3350 10.0% EtGly
分辨率 2.10 Å R-free 0.227
5IID Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 2-(3,4-dihydroxyphenyl)-5-hydroxy-4H-chromen-4-one 提交 2016-03-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 6BK 2-(3,4-dihydroxyphenyl)-5-hydroxy-4H-1-benzopyran-4-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;0.20M Na2SO4 0.1M BTProp pH 8.5 20.0% PEG 3350 10.0% EtGly
分辨率 2.40 Å R-free 0.282
5IID Crystal Structure of the fifth bromodomain of human polybromo (PB1) in complex with 2-(3,4-dihydroxyphenyl)-5-hydroxy-4H-chromen-4-one 提交 2016-03-01 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 6BK 2-(3,4-dihydroxyphenyl)-5-hydroxy-4H-1-benzopyran-4-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;277 K;0.20M Na2SO4 0.1M BTProp pH 8.5 20.0% PEG 3350 10.0% EtGly
分辨率 2.40 Å R-free 0.282
6OXB First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1) 提交 2019-05-13 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 934–1105(172 aa)
未记录 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris HCl pH 8.0 18% sucrose 1.9 M Ammonium sulfate
分辨率 1.86 Å R-free 0.217
6OXB First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1) 提交 2019-05-13 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 934–1105(172 aa)
未记录 SO4 SULFATE ION × 6 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris HCl pH 8.0 18% sucrose 1.9 M Ammonium sulfate
分辨率 1.86 Å R-free 0.217
6OXB First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1) 提交 2019-05-13 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 934–1105(172 aa)
未记录 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris HCl pH 8.0 18% sucrose 1.9 M Ammonium sulfate
分辨率 1.86 Å R-free 0.217
6OXB First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1) 提交 2019-05-13 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 934–1105(172 aa)
未记录 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris HCl pH 8.0 18% sucrose 1.9 M Ammonium sulfate
分辨率 1.86 Å R-free 0.217
6OXB First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1) 提交 2019-05-13 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 934–1105(172 aa)
未记录 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris HCl pH 8.0 18% sucrose 1.9 M Ammonium sulfate
分辨率 1.86 Å R-free 0.217
6OXB First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1) 提交 2019-05-13 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 934–1105(172 aa)
未记录 SO4 SULFATE ION × 5 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris HCl pH 8.0 18% sucrose 1.9 M Ammonium sulfate
分辨率 1.86 Å R-free 0.217
6ZN6 Protein polybromo-1 (PB1 BD2) Bound To MW278 提交 2020-07-06 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 178–291(114 aa)
未记录 QMT 2-[6-azanyl-5-[(3~{R})-3-phenoxypiperidin-1-yl]pyridazin-3-yl]phenol × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.2 M NaCl 25% (w/v) PEG3350 0.1 M bis-tris pH 5.5
分辨率 2.02 Å R-free 0.278
6ZN6 Protein polybromo-1 (PB1 BD2) Bound To MW278 提交 2020-07-06 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 178–291(114 aa)
未记录 QMT 2-[6-azanyl-5-[(3~{R})-3-phenoxypiperidin-1-yl]pyridazin-3-yl]phenol × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.2 M NaCl 25% (w/v) PEG3350 0.1 M bis-tris pH 5.5
分辨率 2.02 Å R-free 0.278
6ZNV Protein polybromo-1 (PB1 BD2) Bound To DP28 提交 2020-07-06 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 178–291(114 aa)
未记录 QMW 1-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperidin-4-ol × 1 ZN ZINC ION × 2 EDO 1,2-ETHANEDIOL × 1 CL CHLORIDE ION × 1 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;277 K;0.005 M zinc acetate 20% (w/v) PEG 3350
分辨率 1.14 Å R-free 0.205
6ZS3 Crystal structure of the fifth bromodomain of human protein polybromo-1 in complex with 2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol 提交 2020-07-15 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 FX5 2-(6-azanyl-5-piperazin-4-ium-1-yl-pyridazin-3-yl)phenol × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;22% (w/v) PEG 3350, 0.2 M sodium malonate, 10% (v/v) ethylene glycol, 0.1 M bis-tris propane pH 7.1
分辨率 1.67 Å R-free 0.243
6ZS3 Crystal structure of the fifth bromodomain of human protein polybromo-1 in complex with 2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol 提交 2020-07-15 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 645–766(122 aa)
未记录 FX5 2-(6-azanyl-5-piperazin-4-ium-1-yl-pyridazin-3-yl)phenol × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;22% (w/v) PEG 3350, 0.2 M sodium malonate, 10% (v/v) ethylene glycol, 0.1 M bis-tris propane pH 7.1
分辨率 1.67 Å R-free 0.243
6ZS4 Crystal structure of the fifth bromodomain of human protein polybromo-1 in complex with tert-butyl 4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazine-1-carboxylate 提交 2020-07-15 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 645–766(122 aa)
未记录 QP8 tert-butyl 4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazine-1-carboxylate × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;30% PEG 5000 MME, 0.2 M (NH4)2SO4, 0.1 M MES pH 5.8
分辨率 2.00 Å R-free 0.230
7VDV The overall structure of human chromatin remodeling PBAF-nucleosome complex 提交 2021-09-07 Assembly 1 蛋白–DNA 异源复合物;蛋白 × 22 PDB 声明:24-meric(24) 与全部聚合物一致
链 a 631–1689(1059 aa)
未记录 BEF BERYLLIUM TRIFLUORIDE ION × 1 MG MAGNESIUM ION × 1 ADP ADENOSINE-5'-DIPHOSPHATE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.5
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
7Y8R The nucleosome-bound human PBAF complex 提交 2022-06-24 Assembly 1 蛋白–DNA 异源复合物;蛋白 × 25 PDB 声明:27-meric(27) 与全部聚合物一致
链 U 1–1597(1597 aa)
未记录 ADP ADENOSINE-5'-DIPHOSPHATE × 1 MG MAGNESIUM ION × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.40 Å
8FTA Crystal Structure of the second bromodomain of human Polybromo-1 (PB1) in complex with compound 16 提交 2023-01-11 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 178–291(114 aa)
未记录 Y8X (2S)-5-chloro-2-(3-methylphenyl)-2,3-dihydroquinazolin-4(1H)-one × 1 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;0.1 M MES pH 5.5, 14.4% PEG 8000, 10% Ethylene Glycol, 0.01M ZnCl2
分辨率 1.78 Å R-free 0.207